国家和国际黑色素瘤皮肤癌治疗指南之间的比较
Michele Rudari1, Raphael Brooks1, Adrian Dragu1
1Department of Plastic and Hand Surgery, University Hospital Carl Gustav Carus at the TU, Dresden, Germany.
Clinics in dermatology
|February 8, 2025
概括
黑色素瘤皮肤癌的临床实践指南显示,在诊断和治疗方面存在显著一致. 关键的区别包括淋巴结超声波时间和S100B瘤标志物在皮肤黑色素瘤监测中的使用.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 临床实践指南 临床实践指南
背景情况:
- 黑色素瘤皮肤癌的管理依赖于基于证据的临床实践指南.
- 国际指南为诊断和治疗提供了不同的建议.
- 将这些准则进行比较对于标准化黑色素瘤护理至关重要.
研究的目的:
- 将治疗和诊断策略与国际公认的黑色素瘤皮肤癌临床实践指南进行比较.
- 在指导方针建议中确定协议和分歧的领域.
- 为皮肤黑色素瘤管理提供最佳实践信息.
主要方法:
- 对黑色素瘤皮肤癌国家和国际公认的临床实践指南的分析.
- 包括来自美国 (美国皮肤病学会),德国 (S3-Leitlinie黑色素瘤) 和澳大利亚 (澳大利亚癌症委员会) 的指南.
- 对诊断和治疗方法的比较评估,重点是手术干预,淋巴结评估和瘤标记物的利用.
主要成果:
- 在皮肤黑色素瘤的诊断方法中观察到广泛的一致性,特别是在手术干预和治疗区域淋巴结干涉的治疗中.
- 发现了一个关键的区别:德国的指导方针建议从IB期开始对淋巴结进行超声波检查,而美国和澳大利亚的指导方针则建议只有在看守淋巴结活检是不可行的或被拒绝的情况下.
- 瘤标志物S100B对III期黑色素瘤评估的差异:德国指南支持其用于基线监测,与美国和澳大利亚指南不同.
结论:
- 尽管存在小差异,但主要的国际黑色素瘤临床实践指南之间存在显著的共识.
- 关于淋巴结超声波和S100B瘤标志物监测的不同建议突出了潜在的未来协调的领域.
- 这些发现支持在主要国际指南中对皮肤黑色素瘤的整体管理达成相当多的共识.
相关概念视频
Skin Cancer
3.0K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.0K
Tumor Immunotherapy
464
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
464
Changes in Skin Color: Clinical Perspectives
1.6K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
1.6K
Cancer Survival Analysis
321
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
321
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


